SCHEMBL7814935

SCHEMBL7814935

CCc1ccc2c(c1)n[c]n2C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
GAA P10253 3/20 0.36
HPGD P15428 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
LMNA P02545 2/20 0.36
HTT P42858 2/20 0.36
KDM4E B2RXH2 2/20 0.36
HSD17B10 Q99714 2/20 0.36
ALOX15 P16050 1/20 0.36
PARP15 Q460N3 1/20 0.36
PARP10 Q53GL7 1/20 0.36
TNKS2 Q9H2K2 1/20 0.36
PARP2 Q9UGN5 1/20 0.36
TRPA1 O75762 1/20 0.34
MAPT P10636 3/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
TRPC5 Q9UL62 6/20 0.33
ALDH1A1 P00352 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7818322 0.86 MAP3K14 (0.38) NPC1RAB9AGAAHPGDSMN1; SMN2
SCHEMBL5982296 0.76 FGFR1 (0.39) KDM4EHSD17B10MAPTMEN1KMT2A
SCHEMBL7812496 0.75 MAPT (0.55) HPGDLMNAHTTKDM4EHSD17B10
SCHEMBL7818433 0.74 FGFR1 (0.38) GAAHPGDSMN1; SMN2KDM4EMEN1
SCHEMBL1831006 0.74 KMT2A (0.38) HPGDKDM4EHSD17B10MAPTMEN1
SCHEMBL1099044 0.74 KMT2A (0.41) GAAHPGDKDM4EHSD17B10MAPT
SCHEMBL7817980 0.74 NPC1 (0.40) NPC1RAB9ASMN1; SMN2HTTALOX15
SCHEMBL7812089 0.72 FGFR1 (0.50) SMN1; SMN2LMNAHTTMAPTKMT2A
SCHEMBL3652546 0.71 TDP1 (0.44) NPC1RAB9AHPGDSMN1; SMN2LMNA
SCHEMBL7815089 0.71 HTR1D (0.36) NPC1RAB9AGAAHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0745600-B1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-10-24 EP disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 EP disclosed